Related Experiment Video
Updated: May 30, 2026

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
Published on: May 19, 2018
New horizons for stem cell therapy in liver disease
Stuart J Forbes1, Philip N Newsome
1MRC Centre for Regenerative Medicine and MRC, Edinburgh University, UK. stuart.forbes@ed.ac.uk
Abstract:
There is an increasing range of potential applications of stem cells in liver diseases, with many clinical studies already undertaken. We identify four of the main areas which we propose stem cell therapy could be a realistic aim for in the future: (1) to improve regeneration and reduce scarring in liver cirrhosis by modulating the liver's own regenerative processes, (2) to down-regulate immune mediated liver damage, (3) supplying hepatocyte-like cells (HLCs) derived from stem cells for use in extracorporeal bio-artificial liver machines, and (4) to use stem cell derived HLCs for cell transplantation to supplement or replace hepatocyte function.
Insights
Stem cell therapy shows promise for liver diseases by enhancing regeneration, reducing immune damage, and providing cells for artificial livers or transplantation. Future applications aim to improve liver function and reduce scarring.
Area of Science:
- Regenerative Medicine
- Hepatology
- Immunology
Background:
- Liver diseases pose a significant health burden with limited treatment options.
- Stem cell research offers novel therapeutic avenues for liver regeneration and repair.
Purpose of the Study:
- To outline future applications of stem cell therapy in managing liver diseases.
- To explore stem cells' potential in modulating liver regeneration, immune responses, and cell-based therapies.
Main Methods:
- Review of current stem cell applications in liver disease research.
- Identification of key areas for future stem cell therapy development.
Main Results:
- Stem cells can modulate liver regeneration and reduce fibrosis in cirrhosis.
- Potential for stem cells to down-regulate immune-mediated liver injury.
- Development of hepatocyte-like cells (HLCs) from stem cells for bio-artificial livers and transplantation.
Conclusions:
- Stem cell therapy presents a realistic future for treating liver cirrhosis by enhancing regeneration and reducing scarring.
- Modulating immune responses with stem cells can mitigate liver damage.
- Stem cell-derived HLCs offer viable options for cell transplantation and bio-artificial liver devices, potentially restoring hepatocyte function.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation
Stem Cell Culture
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Induced Pluripotent Stem Cells

